Regulatory News
Thursday, January 19, 2017
BRIEF-U.S FDA acknowledges receipt of Shire's ADHD drug application
* U.S. FDA acknowledges receipt of Shire's new drug
application for SHP465 for ADHD
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment